Development Stage: Research-Grade Metabolic Assay Development
Short Description
Standard colorimetric measurement of glucose.
Brand
OXPHOSight
Development Stage
Research-Grade Metabolic Assay Development
Description
The OXPHOSight™ Glucose Assay Kit employs a versatile glucose oxidase method to provide basic metabolic profiling for diabetes and obesity drug discovery. This assay is fundamental for monitoring blood glucose regulation and insulin sensitivity in animal models. It supports the high-throughput screening of hypoglycemic agents, ensuring reliable data for efficacy testing in metabolic disease research.
Features
Versatile glucose oxidase method; Basic metabolic profiling for diabetes and obesity drug discovery.
Process Relevance
Metabolic Disease Efficacy Testing
Application Stage
Pre-clinical Efficacy
Applications
Basic metabolic profiling and diabetes research.
Qualified With
Internal performance validation using reference standards under defined assay conditions.
Detection Method
Absorbance at 630 nm (Chemical)
Sample Type
Biological, food, and beverage
Research Areas
Diabetes & Obesity; Endocrinology
Size
100 tests
Data Output Type
Quantitative (Concentration)
Assay Time
Results in 10 min
LOD
0.7 mg/dL (39 µM)
Species
All Species
Storage
Store at −20 °C upon receipt to maintain reagent stability. Follow recommended handling procedures to ensure consistent assay performance.
Storage Comment
Avoid repeated freeze-thaw cycles. During use, minimize the time components are exposed to room temperature and return them promptly to −20 °C storage after handling. Do not store at elevated temperatures for extended periods.
Expiry Date
12 months under recommended storage conditions to ensure optimal performance.
Note
For bulk pricing or custom reagent inquiries, please contact us by email or phone. Products are shipped on ice via FedEx.
Restrictions
For Research Use Only (RUO). Not intended for diagnostic or therapeutic use.
Shipping
Shipped on ice under temperature-controlled conditions.
Background
Glucose is the primary energy source for most cells. Blood glucose regulation is the central focus of diabetes management; chronic hyperglycemia leads to tissue damage while hypoglycemia causes acute impairment.